Cannabis-based Medicines

Patrick Grady Excerpts

Tuesday 19th June 2018 Commons Chamber

[Sajid Javid]

My hon. Friend is right. The process should absolutely be clinically led. We should listen to evidence from clinicians while drawing on international evidence, too. That is exactly what should feed into the outcome of the review.

[Patrick Grady (Glasgow North) (SNP)]

I think we all welcome the progress that is being made, but there are questions about people who need help now. My constituents Laura Murray and John Ahern have a one-year-old daughter, Bláthnaid, who has been diagnosed with Aicardi syndrome. She suffers very severe seizures throughout the day and her parents believe that these medicines could help. I will write to the Home Secretary with more details about that situation, but may I ask him how much discretion he still has, and how much he is willing to exercise?

[Sajid Javid]

As the rules stand, until the review is complete and changes are made, any use of cannabis for medicinal purposes will require a Home Office licence or, in the case of Northern Ireland, a licence from the Health Department there. I hope that what I have set out today has given reassurance that I recognise the need for action now, not tomorrow or in a few weeks or months. We need action now, and that is the purpose of the expert panel—to make this a much smooth, quick and clinically-led process.